Skip to content

Boston Scientific BSX Enterprise value

Enterprise value at other companies

Abbott logo
AbbottABT
$205.65B-13.1%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Stryker logo
StrykerSYK
$137.35B-12.4%
Edwards Lifesciences logo
Edwards LifesciencesEW
$44.42B+11.0%
Medtronic logo
MedtronicMDT
$131.22B-3.2%
STERIS logo
STERISSTE
$23.33B-4.5%

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.4%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$66.81B-37.5%
P/E18.8×-34.0×
P/S3.2×-2.8×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Calculated from Boston Scientific’s reported figures.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's enterprise value?
Boston Scientific (BSX) reported enterprise value of $141.04B in Q4 2025.
How has Boston Scientific's enterprise value changed year-over-year?
Boston Scientific's enterprise value decreased by 1.0% year-over-year, from $142.51B to $141.04B.
What is the long-term trend for Boston Scientific's enterprise value?
Over 4 years (2021 to 2025), Boston Scientific's enterprise value has grown at a 22.7% compound annual growth rate (CAGR), from $275.02B to $623.31B.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.